Alanoud Alomair

Dr. Alanoud Alomair

Princess Nourah bint Abdulrahman University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAlya AlZabin
Alya AlZabin
AAAlanoud Alomair
Alanoud Alomair
EAEbtesam Almajed
Ebtesam Almajed
AAAbdulrahman AlHumaizi
Abdulrahman AlHumaizi
RAReem AlJurayyed
Reem AlJurayyed
Patient satisfaction and knowledge are recognized indicators of healthcare quality in specialized services such as otorhinolaryngology (ORL). This study aimed to assess patient satisfaction and knowledge to identify opportunities for improvement in a Saudi outpatient ORL setting. A cross-sectional study was carried out from July 2024 to January 2025 involving 180 adult patients at the outpatient ORL clinic of King Abdullah bin Abdulaziz University Hospital. A validated self-administered electronic questionnaire evaluated sociodemographic data, satisfaction across five domains, and disease-related knowledge. Satisfaction was measured with a 7-point Likert scale. The statistical analysis included descriptive statistics, correlation analysis, and comparative tests. The majority of participants were Saudi (176, 97.8%) and female (135, 75%), with a mean age of 33.5 years (SD = 12.5). Overall satisfaction was high (mean = 6.14 ± 1.12), with the highest scores in Staff Quality (6.31) and Communication (6.17), and the lowest in Access and Efficiency (5.79). Strong positive correlations were observed among satisfaction domains, particularly between Overall Experience and Staff Quality (r = 0.893, p < 0.001). Disease-related knowledge was also high (mean = 81.93%), particularly regarding medication administration (95.71%) and diagnosis awareness (93.29%). However, knowledge gaps were noted in the understanding of medication side effects (62.75%) and surgical complications (74.31%). Surgical patients reported significantly higher satisfaction (mean difference = 0.35, 95% CI: 0.02–0.68, p = 0.039). Patients expressed high satisfaction with ORL care, particularly in terms of staff quality and communication. Nonetheless, access and patient education on treatment risks require attention. These findings underscore the need for targeted education and service delivery enhancements to improve patient-centered care.

17 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
AAAlanoud Alomair
Alanoud Alomair
AAAlanood Abdulrhman Almusaiteer
Alanood Abdulrhman Almusaiteer
RAReem Mohammed Ababtain
Reem Mohammed Ababtain
SASara Essa Alotaibi
Sara Essa Alotaibi
RARana Hrimal Alotibi
Rana Hrimal Alotibi
DADeema Munif Alotaibi
Deema Munif Alotaibi
Background: Biologic therapies have improved outcomes in patients with severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP), but reliable biomarkers predicting treatment response remain unclear. This systematic review and meta-analysis evaluated predictive biomarkers associated with response to biologic therapy. Methods: A systematic review of randomized controlled trials and observational studies evaluating biomarkers of response to biologic therapy in severe uncontrolled CRSwNP was conducted. Data were extracted using a standardized form, and quantitative synthesis was performed where appropriate. Risk of bias was assessed using the Cochrane risk-of-bias 2 tool and the Newcastle–Ottawa Scale. Results: The most frequently investigated predictors of treatment response included blood eosinophil count, serum IgE, tissue eosinophilia, FeNO, and clinical characteristics such as comorbid asthma and NSAID-exacerbated respiratory disease (NSAID-ERD). Biologic therapy consistently improved clinical outcomes; however, evidence supporting any single biomarker as a reliable predictor of treatment response remained inconsistent because of substantial heterogeneity across studies. Conclusions: Current evidence does not support a universally validated predictive biomarker for biologic response in severe uncontrolled CRSwNP. Further standardized, prospective studies are needed to enable personalized biologic therapy.